| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Spinal Cord | 28 | 2020 | 1812 | 1.770 |
Why?
|
| Compressive Strength | 3 | 2021 | 159 | 1.400 |
Why?
|
| Lumbar Vertebrae | 6 | 2021 | 1886 | 1.390 |
Why?
|
| Spinal Cord Injuries | 14 | 2007 | 928 | 1.280 |
Why?
|
| Thoracic Vertebrae | 4 | 2021 | 613 | 1.200 |
Why?
|
| Osteolysis | 2 | 2021 | 274 | 1.170 |
Why?
|
| Spinal Neoplasms | 3 | 2021 | 715 | 1.010 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 13 | 2019 | 2815 | 0.910 |
Why?
|
| Neuroradiography | 21 | 2006 | 71 | 0.840 |
Why?
|
| Axons | 11 | 2005 | 1677 | 0.790 |
Why?
|
| Magnetic Resonance Imaging | 82 | 2021 | 36741 | 0.790 |
Why?
|
| Spine | 6 | 2021 | 1140 | 0.720 |
Why?
|
| Cadaver | 5 | 2021 | 1364 | 0.560 |
Why?
|
| Magnetic Resonance Spectroscopy | 32 | 2016 | 3782 | 0.510 |
Why?
|
| Radiology | 3 | 2021 | 2104 | 0.490 |
Why?
|
| Bone Density | 4 | 2021 | 3573 | 0.460 |
Why?
|
| Joint Instability | 1 | 2021 | 803 | 0.440 |
Why?
|
| Bone Cements | 1 | 2015 | 327 | 0.430 |
Why?
|
| Tomography, X-Ray Computed | 34 | 2021 | 20762 | 0.390 |
Why?
|
| Radiation Injuries | 5 | 2015 | 1198 | 0.370 |
Why?
|
| Spinal Fractures | 2 | 2015 | 710 | 0.370 |
Why?
|
| Lampreys | 4 | 2004 | 32 | 0.350 |
Why?
|
| Image Enhancement | 8 | 2011 | 2880 | 0.330 |
Why?
|
| Trauma, Nervous System | 1 | 2009 | 35 | 0.320 |
Why?
|
| Spinal Injuries | 2 | 2007 | 300 | 0.300 |
Why?
|
| Spinal Cord Diseases | 4 | 2020 | 291 | 0.280 |
Why?
|
| Rats | 23 | 2012 | 23782 | 0.270 |
Why?
|
| Diffusion | 8 | 2003 | 815 | 0.270 |
Why?
|
| Image Processing, Computer-Assisted | 9 | 2018 | 9016 | 0.250 |
Why?
|
| Retrograde Degeneration | 1 | 2005 | 8 | 0.250 |
Why?
|
| Red Nucleus | 1 | 2005 | 11 | 0.240 |
Why?
|
| Anisotropy | 4 | 2016 | 1292 | 0.220 |
Why?
|
| Rats, Sprague-Dawley | 12 | 2012 | 8142 | 0.210 |
Why?
|
| Keratins | 1 | 2004 | 499 | 0.210 |
Why?
|
| Physicians | 1 | 2021 | 4598 | 0.210 |
Why?
|
| Brain-Derived Neurotrophic Factor | 2 | 2005 | 605 | 0.210 |
Why?
|
| Skull | 2 | 2021 | 829 | 0.200 |
Why?
|
| Certification | 1 | 2006 | 420 | 0.200 |
Why?
|
| Nerve Regeneration | 2 | 2005 | 797 | 0.190 |
Why?
|
| Body Water | 4 | 2018 | 340 | 0.180 |
Why?
|
| Echo-Planar Imaging | 1 | 2004 | 648 | 0.180 |
Why?
|
| Education, Medical, Continuing | 1 | 2006 | 829 | 0.180 |
Why?
|
| Finite Element Analysis | 2 | 2018 | 442 | 0.170 |
Why?
|
| Cranial Nerves | 1 | 2000 | 97 | 0.170 |
Why?
|
| Observer Variation | 3 | 2021 | 2621 | 0.170 |
Why?
|
| Radiation Protection | 2 | 2014 | 428 | 0.170 |
Why?
|
| Lateral Ventricles | 1 | 2021 | 142 | 0.170 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 2 | 2019 | 1232 | 0.170 |
Why?
|
| Diagnostic Imaging | 6 | 2007 | 3533 | 0.170 |
Why?
|
| Cephalometry | 1 | 2021 | 380 | 0.160 |
Why?
|
| Air Bags | 1 | 1998 | 12 | 0.160 |
Why?
|
| Brain Diseases | 12 | 1997 | 1554 | 0.160 |
Why?
|
| Brain Neoplasms | 15 | 2015 | 9118 | 0.160 |
Why?
|
| Neuroglia | 1 | 2004 | 960 | 0.160 |
Why?
|
| Periventricular Nodular Heterotopia | 2 | 2009 | 57 | 0.150 |
Why?
|
| Sensitivity and Specificity | 11 | 2021 | 14729 | 0.150 |
Why?
|
| Aged | 39 | 2021 | 171502 | 0.150 |
Why?
|
| Multiple Sclerosis | 6 | 2011 | 3250 | 0.150 |
Why?
|
| Thrombolytic Therapy | 1 | 2007 | 2055 | 0.150 |
Why?
|
| Computer Simulation | 6 | 2003 | 6283 | 0.150 |
Why?
|
| Neck | 3 | 2018 | 736 | 0.150 |
Why?
|
| Perfusion Imaging | 1 | 2019 | 195 | 0.150 |
Why?
|
| Fractures, Spontaneous | 1 | 2019 | 232 | 0.150 |
Why?
|
| Spinal Nerve Roots | 1 | 1998 | 122 | 0.150 |
Why?
|
| Fibrinolytic Agents | 1 | 2007 | 2080 | 0.140 |
Why?
|
| Sciatica | 1 | 1998 | 97 | 0.140 |
Why?
|
| Reproducibility of Results | 10 | 2021 | 20225 | 0.140 |
Why?
|
| Humans | 144 | 2021 | 768171 | 0.140 |
Why?
|
| Spinal Diseases | 3 | 1993 | 561 | 0.140 |
Why?
|
| Middle Aged | 56 | 2021 | 223487 | 0.140 |
Why?
|
| Thigh | 1 | 1998 | 239 | 0.140 |
Why?
|
| Female | 65 | 2021 | 397187 | 0.130 |
Why?
|
| Fibroblasts | 2 | 2005 | 4178 | 0.130 |
Why?
|
| Cerebral Hemorrhage | 12 | 2008 | 2654 | 0.130 |
Why?
|
| Stroke | 4 | 2019 | 9755 | 0.130 |
Why?
|
| Cerebral Arterial Diseases | 1 | 1996 | 82 | 0.130 |
Why?
|
| Brain Mapping | 1 | 2011 | 6684 | 0.130 |
Why?
|
| Societies, Medical | 1 | 2007 | 3968 | 0.120 |
Why?
|
| Deep Brain Stimulation | 2 | 2014 | 850 | 0.120 |
Why?
|
| Contusions | 2 | 1994 | 78 | 0.120 |
Why?
|
| Leukoencephalopathy, Progressive Multifocal | 2 | 2014 | 133 | 0.120 |
Why?
|
| Dyslexia | 2 | 2007 | 215 | 0.120 |
Why?
|
| Central Nervous System Diseases | 4 | 1995 | 520 | 0.120 |
Why?
|
| Shear Strength | 1 | 2015 | 160 | 0.120 |
Why?
|
| Animals | 42 | 2012 | 169285 | 0.120 |
Why?
|
| Schools, Medical | 1 | 2021 | 883 | 0.120 |
Why?
|
| Nerve Fibers, Myelinated | 4 | 2013 | 952 | 0.110 |
Why?
|
| Pyramidal Tracts | 1 | 2016 | 251 | 0.110 |
Why?
|
| Brain | 27 | 2021 | 27362 | 0.110 |
Why?
|
| Muscular Diseases | 1 | 1998 | 553 | 0.110 |
Why?
|
| Fuzzy Logic | 2 | 2005 | 58 | 0.110 |
Why?
|
| Faculty, Medical | 1 | 2021 | 1226 | 0.100 |
Why?
|
| Weight-Bearing | 1 | 2015 | 534 | 0.100 |
Why?
|
| Spinal Cord Neoplasms | 2 | 1992 | 263 | 0.100 |
Why?
|
| Radio Waves | 2 | 2011 | 250 | 0.100 |
Why?
|
| Glioma | 4 | 2002 | 3503 | 0.100 |
Why?
|
| Phantoms, Imaging | 3 | 2016 | 2512 | 0.090 |
Why?
|
| Adult | 59 | 2021 | 223646 | 0.090 |
Why?
|
| Practice Guidelines as Topic | 1 | 2007 | 7454 | 0.090 |
Why?
|
| Motor Activity | 2 | 2003 | 2711 | 0.090 |
Why?
|
| Male | 61 | 2021 | 364731 | 0.080 |
Why?
|
| Endometriosis | 1 | 1998 | 873 | 0.080 |
Why?
|
| Brain Injuries | 2 | 2014 | 2057 | 0.080 |
Why?
|
| Vertebral Artery Dissection | 1 | 2010 | 48 | 0.080 |
Why?
|
| Artifacts | 3 | 2018 | 1926 | 0.080 |
Why?
|
| Craniocerebral Trauma | 2 | 1991 | 493 | 0.080 |
Why?
|
| Security Measures | 1 | 2010 | 83 | 0.080 |
Why?
|
| Optic Nerve | 2 | 2005 | 571 | 0.080 |
Why?
|
| Psychiatric Department, Hospital | 1 | 2010 | 133 | 0.080 |
Why?
|
| Cerebrovascular Circulation | 1 | 2019 | 2725 | 0.080 |
Why?
|
| Electrodes, Implanted | 1 | 2014 | 836 | 0.080 |
Why?
|
| Hematoma | 5 | 2008 | 766 | 0.080 |
Why?
|
| C-Reactive Protein | 1 | 2021 | 3858 | 0.080 |
Why?
|
| Myelin Sheath | 2 | 2012 | 652 | 0.080 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2014 | 3390 | 0.080 |
Why?
|
| Brain Ischemia | 2 | 2019 | 3007 | 0.080 |
Why?
|
| Orbital Neoplasms | 5 | 1988 | 223 | 0.080 |
Why?
|
| Cervical Vertebrae | 2 | 2009 | 979 | 0.080 |
Why?
|
| Imaging, Three-Dimensional | 3 | 2011 | 4064 | 0.080 |
Why?
|
| Algorithms | 4 | 2021 | 14164 | 0.080 |
Why?
|
| Range of Motion, Articular | 1 | 2015 | 1597 | 0.080 |
Why?
|
| Contrast Media | 5 | 2011 | 5330 | 0.080 |
Why?
|
| Absorptiometry, Photon | 1 | 2014 | 1758 | 0.080 |
Why?
|
| Safety | 3 | 2010 | 1159 | 0.080 |
Why?
|
| Radiation Dosage | 2 | 2014 | 1967 | 0.070 |
Why?
|
| Wounds, Nonpenetrating | 2 | 1994 | 807 | 0.070 |
Why?
|
| Models, Biological | 2 | 2021 | 9497 | 0.070 |
Why?
|
| Injections, Intra-Arterial | 1 | 2007 | 181 | 0.070 |
Why?
|
| Adipose Tissue | 2 | 2018 | 3334 | 0.070 |
Why?
|
| Fractures, Bone | 1 | 2019 | 2062 | 0.070 |
Why?
|
| Fibrinolysin | 1 | 2007 | 130 | 0.070 |
Why?
|
| Seizures | 4 | 2014 | 2998 | 0.070 |
Why?
|
| Bone Neoplasms | 1 | 2019 | 2565 | 0.070 |
Why?
|
| Brain Edema | 2 | 2008 | 601 | 0.070 |
Why?
|
| Neural Pathways | 3 | 2007 | 3117 | 0.070 |
Why?
|
| Monte Carlo Method | 2 | 2011 | 1259 | 0.070 |
Why?
|
| Intracranial Aneurysm | 5 | 1996 | 1271 | 0.070 |
Why?
|
| Cerebral Cortex | 4 | 2014 | 5812 | 0.070 |
Why?
|
| Iophendylate | 1 | 1986 | 3 | 0.070 |
Why?
|
| Iodobenzenes | 1 | 1986 | 23 | 0.070 |
Why?
|
| Aged, 80 and over | 14 | 2021 | 59626 | 0.070 |
Why?
|
| Predictive Value of Tests | 7 | 2021 | 15453 | 0.070 |
Why?
|
| Accidental Falls | 1 | 2014 | 1080 | 0.070 |
Why?
|
| Bromocriptine | 1 | 1986 | 93 | 0.070 |
Why?
|
| Thymidine Kinase | 2 | 1997 | 286 | 0.070 |
Why?
|
| Ganciclovir | 2 | 1997 | 256 | 0.070 |
Why?
|
| Atrophy | 5 | 2021 | 1646 | 0.060 |
Why?
|
| Radiosurgery | 1 | 2015 | 1330 | 0.060 |
Why?
|
| Least-Squares Analysis | 1 | 2006 | 367 | 0.060 |
Why?
|
| Larva | 2 | 2004 | 515 | 0.060 |
Why?
|
| Software | 1 | 2019 | 4480 | 0.060 |
Why?
|
| Optic Chiasm | 1 | 2005 | 91 | 0.060 |
Why?
|
| Statistics, Nonparametric | 1 | 2011 | 2862 | 0.060 |
Why?
|
| Ferritins | 1 | 2008 | 601 | 0.060 |
Why?
|
| Social Environment | 1 | 2010 | 1012 | 0.060 |
Why?
|
| Parkinson Disease | 3 | 2014 | 2893 | 0.060 |
Why?
|
| Adenoviridae | 2 | 2001 | 1093 | 0.060 |
Why?
|
| Cranial Nerve Diseases | 1 | 2005 | 111 | 0.060 |
Why?
|
| Spinal Cord Compression | 1 | 1986 | 234 | 0.060 |
Why?
|
| Cysts | 3 | 1994 | 685 | 0.060 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2013 | 1164 | 0.060 |
Why?
|
| Serum Albumin | 1 | 1987 | 677 | 0.060 |
Why?
|
| Edema | 2 | 1994 | 765 | 0.060 |
Why?
|
| Radiography | 7 | 1998 | 6986 | 0.060 |
Why?
|
| Pituitary Neoplasms | 3 | 1988 | 1322 | 0.060 |
Why?
|
| Porosity | 1 | 2004 | 352 | 0.060 |
Why?
|
| Data Interpretation, Statistical | 1 | 2013 | 2709 | 0.050 |
Why?
|
| Simplexvirus | 2 | 1997 | 805 | 0.050 |
Why?
|
| Nervous System Malformations | 1 | 2005 | 243 | 0.050 |
Why?
|
| Motion | 1 | 2006 | 790 | 0.050 |
Why?
|
| Hindlimb | 1 | 2005 | 516 | 0.050 |
Why?
|
| Pericarditis | 1 | 1984 | 136 | 0.050 |
Why?
|
| Radiotherapy, Conformal | 1 | 2005 | 549 | 0.050 |
Why?
|
| Body Fluid Compartments | 1 | 2002 | 50 | 0.050 |
Why?
|
| Head and Neck Neoplasms | 2 | 2013 | 2931 | 0.050 |
Why?
|
| Cells | 1 | 2003 | 166 | 0.050 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2007 | 1165 | 0.050 |
Why?
|
| United States | 4 | 2021 | 73039 | 0.050 |
Why?
|
| Nervous System Diseases | 3 | 1997 | 1662 | 0.050 |
Why?
|
| Glioblastoma | 3 | 2005 | 3464 | 0.050 |
Why?
|
| Myelography | 4 | 1990 | 72 | 0.040 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2015 | 9419 | 0.040 |
Why?
|
| Immunohistochemistry | 2 | 2004 | 11095 | 0.040 |
Why?
|
| Cerebral Angiography | 5 | 1996 | 1264 | 0.040 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2003 | 508 | 0.040 |
Why?
|
| Recovery of Function | 2 | 2016 | 2981 | 0.040 |
Why?
|
| Demyelinating Diseases | 3 | 1992 | 358 | 0.040 |
Why?
|
| Rats, Wistar | 2 | 2000 | 1890 | 0.040 |
Why?
|
| Trigeminal Nerve | 1 | 2000 | 248 | 0.040 |
Why?
|
| Interferon-beta | 1 | 2001 | 349 | 0.040 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 1986 | 1024 | 0.040 |
Why?
|
| Trauma Severity Indices | 1 | 2000 | 479 | 0.040 |
Why?
|
| Adolescent | 30 | 2021 | 89169 | 0.040 |
Why?
|
| Statistics as Topic | 1 | 2005 | 2357 | 0.040 |
Why?
|
| Lumbosacral Plexus | 1 | 1998 | 53 | 0.040 |
Why?
|
| Femoral Nerve | 1 | 1998 | 42 | 0.040 |
Why?
|
| Models, Neurological | 2 | 2003 | 1776 | 0.040 |
Why?
|
| Hypesthesia | 1 | 1998 | 106 | 0.040 |
Why?
|
| Young Adult | 9 | 2021 | 60066 | 0.040 |
Why?
|
| Acute Disease | 6 | 2008 | 7243 | 0.040 |
Why?
|
| Patient Satisfaction | 1 | 2010 | 3490 | 0.040 |
Why?
|
| Prospective Studies | 5 | 2018 | 54924 | 0.040 |
Why?
|
| Paresthesia | 1 | 1998 | 160 | 0.040 |
Why?
|
| Genetic Vectors | 2 | 1997 | 3403 | 0.030 |
Why?
|
| Microscopy, Electron | 1 | 2000 | 2560 | 0.030 |
Why?
|
| Patient Selection | 2 | 2007 | 4260 | 0.030 |
Why?
|
| Orbital Diseases | 3 | 1987 | 178 | 0.030 |
Why?
|
| Automation | 1 | 2019 | 589 | 0.030 |
Why?
|
| Back Pain | 1 | 2021 | 548 | 0.030 |
Why?
|
| Microscopy | 1 | 2002 | 909 | 0.030 |
Why?
|
| Defective Viruses | 1 | 1996 | 89 | 0.030 |
Why?
|
| Menstruation | 1 | 1998 | 310 | 0.030 |
Why?
|
| Gliosis | 2 | 1988 | 246 | 0.030 |
Why?
|
| Leuprolide | 1 | 1998 | 313 | 0.030 |
Why?
|
| Linear Models | 1 | 2006 | 5884 | 0.030 |
Why?
|
| Epilepsy | 2 | 2009 | 3326 | 0.030 |
Why?
|
| Child, Preschool | 19 | 2021 | 42669 | 0.030 |
Why?
|
| Adenoviridae Infections | 1 | 1996 | 96 | 0.030 |
Why?
|
| Risk Assessment | 3 | 2014 | 24318 | 0.030 |
Why?
|
| Cell Division | 1 | 2003 | 4477 | 0.030 |
Why?
|
| Orbit | 3 | 1987 | 459 | 0.030 |
Why?
|
| Retrospective Studies | 10 | 2021 | 81760 | 0.030 |
Why?
|
| Calibration | 1 | 2018 | 819 | 0.030 |
Why?
|
| Paranasal Sinus Diseases | 2 | 1987 | 121 | 0.030 |
Why?
|
| Radionuclide Imaging | 1 | 2019 | 2000 | 0.030 |
Why?
|
| Hydrocephalus | 2 | 2021 | 768 | 0.030 |
Why?
|
| Behavior, Animal | 1 | 2003 | 1862 | 0.030 |
Why?
|
| Nerve Degeneration | 2 | 2002 | 749 | 0.030 |
Why?
|
| Models, Structural | 4 | 2003 | 340 | 0.030 |
Why?
|
| Muscle Weakness | 1 | 1998 | 412 | 0.030 |
Why?
|
| Permeability | 1 | 1997 | 726 | 0.030 |
Why?
|
| Skull Fractures | 2 | 1987 | 203 | 0.030 |
Why?
|
| Peptide Fragments | 1 | 2007 | 5151 | 0.030 |
Why?
|
| Child | 27 | 2021 | 80917 | 0.030 |
Why?
|
| Adenoviruses, Human | 1 | 1996 | 257 | 0.030 |
Why?
|
| Physical Therapy Modalities | 1 | 1998 | 533 | 0.030 |
Why?
|
| Sciatic Nerve | 1 | 1998 | 628 | 0.030 |
Why?
|
| Dilatation, Pathologic | 1 | 1996 | 527 | 0.030 |
Why?
|
| Antiviral Agents | 2 | 1997 | 3072 | 0.030 |
Why?
|
| Spin Labels | 1 | 2015 | 336 | 0.030 |
Why?
|
| Mental Disorders | 2 | 2010 | 6873 | 0.030 |
Why?
|
| Cerebral Infarction | 3 | 1988 | 969 | 0.030 |
Why?
|
| Disease Models, Animal | 2 | 2003 | 18349 | 0.030 |
Why?
|
| Graft Survival | 1 | 2003 | 3887 | 0.030 |
Why?
|
| Tomography, Emission-Computed | 2 | 1999 | 1126 | 0.020 |
Why?
|
| Diffusion Tensor Imaging | 2 | 2016 | 2420 | 0.020 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 1998 | 716 | 0.020 |
Why?
|
| Reference Values | 3 | 2009 | 4939 | 0.020 |
Why?
|
| Astrocytoma | 1 | 1996 | 774 | 0.020 |
Why?
|
| Natural Language Processing | 1 | 2021 | 1203 | 0.020 |
Why?
|
| Ligaments | 1 | 1992 | 127 | 0.020 |
Why?
|
| Cognition | 1 | 2009 | 7073 | 0.020 |
Why?
|
| Neurologic Examination | 1 | 1994 | 914 | 0.020 |
Why?
|
| Hemiplegia | 1 | 1992 | 137 | 0.020 |
Why?
|
| Neuralgia | 1 | 1998 | 622 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2007 | 8052 | 0.020 |
Why?
|
| Cytarabine | 1 | 1993 | 695 | 0.020 |
Why?
|
| Hematoma, Subdural | 2 | 1989 | 128 | 0.020 |
Why?
|
| Essential Tremor | 1 | 2014 | 161 | 0.020 |
Why?
|
| Necrosis | 1 | 2015 | 1616 | 0.020 |
Why?
|
| Intracranial Arteriovenous Malformations | 2 | 1992 | 360 | 0.020 |
Why?
|
| Analgesics | 1 | 1998 | 1071 | 0.020 |
Why?
|
| Heart | 1 | 1984 | 4446 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2000 | 6340 | 0.020 |
Why?
|
| Positron-Emission Tomography | 3 | 2015 | 6669 | 0.020 |
Why?
|
| Cerebral Veins | 1 | 1992 | 157 | 0.020 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2009 | 4640 | 0.020 |
Why?
|
| Intracellular Membranes | 1 | 1991 | 388 | 0.020 |
Why?
|
| Theft | 1 | 2010 | 20 | 0.020 |
Why?
|
| Hemianopsia | 1 | 1992 | 121 | 0.020 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2015 | 1140 | 0.020 |
Why?
|
| Hemoglobins | 3 | 1991 | 1531 | 0.020 |
Why?
|
| Encephalitis | 1 | 2014 | 441 | 0.020 |
Why?
|
| Leukemia, Myeloid | 1 | 1993 | 693 | 0.020 |
Why?
|
| Dangerous Behavior | 1 | 2010 | 65 | 0.020 |
Why?
|
| Dura Mater | 1 | 1992 | 297 | 0.020 |
Why?
|
| Clinical Competence | 1 | 2006 | 4858 | 0.020 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 1998 | 1536 | 0.020 |
Why?
|
| Academic Medical Centers | 1 | 2020 | 2785 | 0.020 |
Why?
|
| Low Back Pain | 1 | 1998 | 990 | 0.020 |
Why?
|
| Lymphangioma | 1 | 1989 | 60 | 0.020 |
Why?
|
| Functional Laterality | 1 | 2016 | 2264 | 0.020 |
Why?
|
| Brain Stem | 3 | 1990 | 859 | 0.020 |
Why?
|
| Intracranial Embolism and Thrombosis | 2 | 1988 | 144 | 0.020 |
Why?
|
| Ossification, Heterotopic | 1 | 1992 | 240 | 0.020 |
Why?
|
| Viral Proteins | 1 | 1996 | 1802 | 0.020 |
Why?
|
| Spinal Stenosis | 1 | 1992 | 259 | 0.020 |
Why?
|
| Wechsler Scales | 1 | 2009 | 256 | 0.020 |
Why?
|
| England | 1 | 2010 | 533 | 0.020 |
Why?
|
| Anti-Inflammatory Agents | 1 | 1998 | 1810 | 0.020 |
Why?
|
| Neoplastic Stem Cells | 1 | 1996 | 1351 | 0.020 |
Why?
|
| Meningioma | 2 | 1988 | 1220 | 0.020 |
Why?
|
| Empyema, Subdural | 1 | 1987 | 12 | 0.020 |
Why?
|
| Osteomyelitis | 1 | 1992 | 408 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1996 | 3740 | 0.020 |
Why?
|
| Models, Theoretical | 2 | 1997 | 3573 | 0.020 |
Why?
|
| Cross-Sectional Studies | 2 | 2021 | 26379 | 0.020 |
Why?
|
| Consciousness Disorders | 1 | 1992 | 445 | 0.020 |
Why?
|
| Cerebral Aqueduct | 1 | 1987 | 39 | 0.020 |
Why?
|
| Extracellular Space | 2 | 1991 | 563 | 0.020 |
Why?
|
| Hemorrhage | 3 | 1994 | 3466 | 0.020 |
Why?
|
| Metrizamide | 1 | 1986 | 17 | 0.020 |
Why?
|
| Hepatolenticular Degeneration | 1 | 1987 | 73 | 0.020 |
Why?
|
| Specialization | 1 | 1991 | 779 | 0.020 |
Why?
|
| Treatment Outcome | 4 | 2016 | 65379 | 0.020 |
Why?
|
| Emergency Service, Hospital | 2 | 2020 | 7951 | 0.020 |
Why?
|
| Cerebellar Diseases | 1 | 1989 | 227 | 0.020 |
Why?
|
| Cerebral Ventriculography | 1 | 1986 | 44 | 0.020 |
Why?
|
| Salvage Therapy | 1 | 1993 | 1273 | 0.020 |
Why?
|
| Encephalomyelitis | 1 | 1986 | 37 | 0.020 |
Why?
|
| Laparoscopy | 1 | 1998 | 2041 | 0.020 |
Why?
|
| Social Perception | 1 | 2010 | 434 | 0.020 |
Why?
|
| Diseases in Twins | 1 | 1988 | 447 | 0.020 |
Why?
|
| Spinal Canal | 1 | 1986 | 41 | 0.020 |
Why?
|
| Neurology | 1 | 1994 | 786 | 0.020 |
Why?
|
| Carcinoid Tumor | 1 | 1987 | 225 | 0.020 |
Why?
|
| Prejudice | 1 | 2010 | 574 | 0.020 |
Why?
|
| Ophthalmoplegia | 1 | 1987 | 168 | 0.020 |
Why?
|
| Cranial Sinuses | 1 | 1986 | 68 | 0.020 |
Why?
|
| Mastoid | 1 | 1986 | 100 | 0.020 |
Why?
|
| Siderosis | 1 | 1987 | 100 | 0.020 |
Why?
|
| Streptokinase | 1 | 1985 | 186 | 0.020 |
Why?
|
| Blast Injuries | 1 | 2009 | 321 | 0.020 |
Why?
|
| Dogs | 3 | 1984 | 3845 | 0.010 |
Why?
|
| Sinus Thrombosis, Intracranial | 1 | 1986 | 110 | 0.010 |
Why?
|
| Chordoma | 1 | 1988 | 349 | 0.010 |
Why?
|
| Pericarditis, Tuberculous | 1 | 1984 | 8 | 0.010 |
Why?
|
| Cerebral Arteries | 1 | 1987 | 488 | 0.010 |
Why?
|
| Liver Abscess | 1 | 1984 | 81 | 0.010 |
Why?
|
| Cerebrovascular Disorders | 2 | 1994 | 1485 | 0.010 |
Why?
|
| Neuropsychological Tests | 2 | 2009 | 7140 | 0.010 |
Why?
|
| Peritoneal Diseases | 1 | 1984 | 76 | 0.010 |
Why?
|
| Craniopharyngioma | 1 | 1987 | 279 | 0.010 |
Why?
|
| Lymphatic Metastasis | 1 | 1992 | 2914 | 0.010 |
Why?
|
| Nasopharyngeal Neoplasms | 1 | 1986 | 290 | 0.010 |
Why?
|
| Prognosis | 1 | 2005 | 30009 | 0.010 |
Why?
|
| Limbic System | 1 | 1986 | 424 | 0.010 |
Why?
|
| Reading | 1 | 2007 | 543 | 0.010 |
Why?
|
| Models, Anatomic | 1 | 1987 | 680 | 0.010 |
Why?
|
| Carotid Artery, Internal | 1 | 1986 | 440 | 0.010 |
Why?
|
| Choristoma | 1 | 2005 | 205 | 0.010 |
Why?
|
| Medicine | 1 | 1991 | 945 | 0.010 |
Why?
|
| Social Behavior | 1 | 2010 | 1147 | 0.010 |
Why?
|
| Time Factors | 5 | 2005 | 40220 | 0.010 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2010 | 1429 | 0.010 |
Why?
|
| Neurofibromatosis 1 | 1 | 1988 | 561 | 0.010 |
Why?
|
| Calcinosis | 2 | 1988 | 1482 | 0.010 |
Why?
|
| Data Collection | 1 | 1991 | 3326 | 0.010 |
Why?
|
| Macaca mulatta | 2 | 2001 | 2363 | 0.010 |
Why?
|
| Temporal Bone | 1 | 1987 | 683 | 0.010 |
Why?
|
| Diagnosis, Differential | 2 | 2015 | 13013 | 0.010 |
Why?
|
| Neuroma, Acoustic | 1 | 1986 | 455 | 0.010 |
Why?
|
| Walking | 1 | 2009 | 1201 | 0.010 |
Why?
|
| Angiography | 1 | 1986 | 1597 | 0.010 |
Why?
|
| Pulmonary Circulation | 1 | 1983 | 745 | 0.010 |
Why?
|
| Abscess | 1 | 1984 | 606 | 0.010 |
Why?
|
| Autistic Disorder | 1 | 1990 | 1240 | 0.010 |
Why?
|
| Intelligence | 1 | 2005 | 926 | 0.010 |
Why?
|
| Methemoglobin | 2 | 1991 | 25 | 0.010 |
Why?
|
| Carmustine | 1 | 1999 | 137 | 0.010 |
Why?
|
| Infant | 10 | 1995 | 36535 | 0.010 |
Why?
|
| Iron | 1 | 2008 | 1813 | 0.010 |
Why?
|
| Oxyhemoglobins | 2 | 1991 | 213 | 0.010 |
Why?
|
| Combined Modality Therapy | 3 | 1999 | 8542 | 0.010 |
Why?
|
| Fluorocarbons | 1 | 1984 | 506 | 0.010 |
Why?
|
| Carotid Artery Diseases | 1 | 1985 | 879 | 0.010 |
Why?
|
| Phenytoin | 1 | 1999 | 189 | 0.010 |
Why?
|
| Referral and Consultation | 1 | 1991 | 3620 | 0.010 |
Why?
|
| Disease Progression | 1 | 2015 | 13668 | 0.010 |
Why?
|
| Anemia, Sickle Cell | 1 | 1987 | 1065 | 0.010 |
Why?
|
| Osmolar Concentration | 2 | 1991 | 657 | 0.010 |
Why?
|
| Sigmodontinae | 1 | 1997 | 8 | 0.010 |
Why?
|
| Meningeal Neoplasms | 1 | 1986 | 1253 | 0.010 |
Why?
|
| Follow-Up Studies | 4 | 2008 | 39354 | 0.010 |
Why?
|
| Cell Membrane Permeability | 1 | 1998 | 573 | 0.010 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 1992 | 4058 | 0.010 |
Why?
|
| Injections, Intralesional | 1 | 1996 | 280 | 0.010 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 1999 | 614 | 0.010 |
Why?
|
| Carcinoma | 1 | 1986 | 2332 | 0.010 |
Why?
|
| Copper Sulfate | 1 | 1994 | 13 | 0.010 |
Why?
|
| Stereotaxic Techniques | 1 | 1997 | 553 | 0.010 |
Why?
|
| Nerve Fibers | 1 | 1998 | 709 | 0.010 |
Why?
|
| Diatrizoate Meglumine | 2 | 1983 | 79 | 0.010 |
Why?
|
| Primates | 1 | 1996 | 520 | 0.010 |
Why?
|
| Triiodobenzoic Acids | 2 | 1983 | 123 | 0.010 |
Why?
|
| Substance-Related Disorders | 1 | 2010 | 4423 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2002 | 3655 | 0.010 |
Why?
|
| Hemodynamics | 1 | 1983 | 4194 | 0.010 |
Why?
|
| Cell Movement | 1 | 2005 | 5213 | 0.010 |
Why?
|
| Iohexol | 2 | 1983 | 205 | 0.010 |
Why?
|
| Thrombosis | 1 | 1987 | 2957 | 0.010 |
Why?
|
| Venous Pressure | 1 | 1992 | 55 | 0.010 |
Why?
|
| Fourier Analysis | 1 | 1993 | 439 | 0.010 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 1997 | 1339 | 0.010 |
Why?
|
| Pentetic Acid | 1 | 1992 | 209 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2005 | 8741 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2003 | 5315 | 0.010 |
Why?
|
| Meglumine | 1 | 1992 | 144 | 0.010 |
Why?
|
| Copper | 1 | 1994 | 368 | 0.010 |
Why?
|
| Genetics, Medical | 1 | 1994 | 334 | 0.010 |
Why?
|
| Cardiac Output | 2 | 1983 | 838 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2009 | 15949 | 0.010 |
Why?
|
| Myocardium | 1 | 1984 | 4790 | 0.010 |
Why?
|
| Phenotype | 1 | 2009 | 16726 | 0.010 |
Why?
|
| Surface Properties | 1 | 1994 | 1166 | 0.010 |
Why?
|
| Electrocardiography | 1 | 1984 | 6412 | 0.010 |
Why?
|
| Clinical Protocols | 1 | 1996 | 1443 | 0.010 |
Why?
|
| Aging | 1 | 1989 | 8743 | 0.010 |
Why?
|
| Informed Consent | 1 | 1996 | 1010 | 0.010 |
Why?
|
| Radiology, Interventional | 1 | 1994 | 483 | 0.010 |
Why?
|
| Epilepsy, Generalized | 1 | 1992 | 181 | 0.010 |
Why?
|
| Anticonvulsants | 1 | 1999 | 1923 | 0.010 |
Why?
|
| Hypertension | 1 | 1989 | 8616 | 0.010 |
Why?
|
| Fixatives | 1 | 1989 | 90 | 0.000 |
Why?
|
| Gadolinium DTPA | 1 | 1992 | 823 | 0.000 |
Why?
|
| Melanoma | 1 | 1987 | 5706 | 0.000 |
Why?
|
| Rabbits | 2 | 1985 | 4773 | 0.000 |
Why?
|
| Transfection | 1 | 1996 | 5756 | 0.000 |
Why?
|
| Infusions, Intravenous | 1 | 1993 | 2230 | 0.000 |
Why?
|
| Organometallic Compounds | 1 | 1992 | 648 | 0.000 |
Why?
|
| Recurrence | 1 | 2001 | 8509 | 0.000 |
Why?
|
| Hemangioma, Cavernous | 1 | 1988 | 107 | 0.000 |
Why?
|
| Gene Expression | 1 | 2001 | 7601 | 0.000 |
Why?
|
| Alzheimer Disease | 1 | 1989 | 8759 | 0.000 |
Why?
|
| Putamen | 1 | 1989 | 291 | 0.000 |
Why?
|
| Malignant Carcinoid Syndrome | 1 | 1987 | 31 | 0.000 |
Why?
|
| Water | 1 | 1994 | 1421 | 0.000 |
Why?
|
| Rats, Inbred Strains | 1 | 1989 | 2087 | 0.000 |
Why?
|
| Hot Temperature | 1 | 1994 | 1440 | 0.000 |
Why?
|
| Uvea | 1 | 1987 | 31 | 0.000 |
Why?
|
| Case-Control Studies | 1 | 2005 | 22290 | 0.000 |
Why?
|
| Barotrauma | 1 | 1987 | 41 | 0.000 |
Why?
|
| Brain Chemistry | 1 | 1991 | 958 | 0.000 |
Why?
|
| Cranial Irradiation | 1 | 1990 | 393 | 0.000 |
Why?
|
| Cerebral Ventricle Neoplasms | 1 | 1987 | 43 | 0.000 |
Why?
|
| Substantia Nigra | 1 | 1989 | 346 | 0.000 |
Why?
|
| Prostheses and Implants | 1 | 1994 | 1277 | 0.000 |
Why?
|
| Risk Factors | 1 | 2014 | 74944 | 0.000 |
Why?
|
| Hematoma, Epidural, Cranial | 1 | 1987 | 59 | 0.000 |
Why?
|
| Hemosiderin | 1 | 1986 | 41 | 0.000 |
Why?
|
| Hematocrit | 1 | 1988 | 623 | 0.000 |
Why?
|
| Survival Rate | 1 | 2001 | 12840 | 0.000 |
Why?
|
| Twins, Monozygotic | 1 | 1988 | 472 | 0.000 |
Why?
|
| Cohort Studies | 1 | 2009 | 41753 | 0.000 |
Why?
|
| Infant, Newborn | 4 | 1987 | 26421 | 0.000 |
Why?
|
| Telangiectasis | 1 | 1986 | 78 | 0.000 |
Why?
|
| Sclera | 1 | 1987 | 189 | 0.000 |
Why?
|
| Equipment Design | 1 | 1994 | 3522 | 0.000 |
Why?
|
| Vascular Diseases | 1 | 1994 | 1162 | 0.000 |
Why?
|
| Drug Combinations | 1 | 1992 | 2089 | 0.000 |
Why?
|
| Neurons | 1 | 2005 | 9514 | 0.000 |
Why?
|
| Eye Neoplasms | 1 | 1987 | 306 | 0.000 |
Why?
|
| Oxidation-Reduction | 1 | 1991 | 2227 | 0.000 |
Why?
|
| Facial Injuries | 1 | 1987 | 191 | 0.000 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1997 | 10763 | 0.000 |
Why?
|
| Hydrocarbons, Brominated | 1 | 1984 | 29 | 0.000 |
Why?
|
| Lung | 1 | 1983 | 10101 | 0.000 |
Why?
|
| Paranasal Sinuses | 1 | 1987 | 267 | 0.000 |
Why?
|
| Basal Ganglia | 1 | 1987 | 553 | 0.000 |
Why?
|
| Molecular Weight | 1 | 1986 | 2173 | 0.000 |
Why?
|
| Fibrinolysis | 1 | 1985 | 331 | 0.000 |
Why?
|
| Oculomotor Muscles | 1 | 1987 | 405 | 0.000 |
Why?
|
| Saline Solution, Hypertonic | 1 | 1983 | 115 | 0.000 |
Why?
|
| Arteriovenous Malformations | 1 | 1986 | 396 | 0.000 |
Why?
|
| Mice, Inbred C57BL | 1 | 2001 | 22380 | 0.000 |
Why?
|
| Embolization, Therapeutic | 1 | 1992 | 1401 | 0.000 |
Why?
|
| Chronic Disease | 2 | 1988 | 9384 | 0.000 |
Why?
|
| Evaluation Studies as Topic | 1 | 1984 | 1627 | 0.000 |
Why?
|
| Mice | 2 | 2001 | 82049 | 0.000 |
Why?
|
| Blood-Brain Barrier | 1 | 1988 | 1035 | 0.000 |
Why?
|
| Corpus Callosum | 1 | 1986 | 752 | 0.000 |
Why?
|
| Palliative Care | 1 | 1996 | 3643 | 0.000 |
Why?
|
| Accidents, Traffic | 1 | 1986 | 818 | 0.000 |
Why?
|
| Hemangioma | 1 | 1986 | 727 | 0.000 |
Why?
|
| Corpus Striatum | 1 | 1987 | 1224 | 0.000 |
Why?
|
| Abnormalities, Multiple | 1 | 1988 | 1424 | 0.000 |
Why?
|
| Thalamus | 1 | 1987 | 1047 | 0.000 |
Why?
|
| Vascular Resistance | 1 | 1983 | 939 | 0.000 |
Why?
|
| Lymph Nodes | 1 | 1992 | 3474 | 0.000 |
Why?
|
| Virus Diseases | 1 | 1986 | 724 | 0.000 |
Why?
|
| Emergencies | 1 | 1986 | 1221 | 0.000 |
Why?
|
| Astrocytes | 1 | 1988 | 1350 | 0.000 |
Why?
|
| Radiographic Image Enhancement | 1 | 1984 | 877 | 0.000 |
Why?
|
| Lymphoma | 1 | 1988 | 1898 | 0.000 |
Why?
|
| Myocardial Contraction | 1 | 1983 | 1526 | 0.000 |
Why?
|
| Blood Pressure | 2 | 1983 | 8543 | 0.000 |
Why?
|
| Glucose | 1 | 1989 | 4352 | 0.000 |
Why?
|
| Neoplasm Invasiveness | 1 | 1986 | 3620 | 0.000 |
Why?
|
| Inflammation | 1 | 1997 | 10873 | 0.000 |
Why?
|
| Drug Administration Schedule | 1 | 1985 | 4861 | 0.000 |
Why?
|
| Biopsy | 1 | 1989 | 6792 | 0.000 |
Why?
|
| Pulmonary Artery | 1 | 1983 | 1946 | 0.000 |
Why?
|
| Heart Rate | 1 | 1983 | 4214 | 0.000 |
Why?
|
| Mutation | 1 | 1988 | 30237 | 0.000 |
Why?
|